• Tuberculosis and Respiratory Diseases
• /
• 제42권2호
• /
• pp.149-155
• /
• 1995

연구목적: Cytokeratin 19는 기관지의 상피세포와 같은 단순 또는 가중층상피세포에 국한된 40KD의 산성 분자로 면역조직학적 검사를 통해 cytokeratin 19가 폐암 조직에서 많이 발현되는 것으로 알려져 있다. Cytokeratin 19에 특징적인 단일 클론 항체 BM 19-21과 KS 19-1을 이용한 면역방사계수법, CYFRA 21-1을 이용하여 cytokeratin 19분절이 폐암 특히 편평상피세포암의 진단에 유용한 표지자가 될 수 있다는 보고가 있어 폐암 표지자로서 CYFRA 21-1의 유용성을 조사해 보기 위하여 본 연구를 하였다. 방법: 저자 등은 영남대학교 의과대학 부속병원 내과에 1993년 4월부터 1994년 8월까지 입원한 원발성 폐암 환자 39명(편평상피 세포암 19명, 선암 11명, 소세포암 9명)을 폐암군으로, 비악성 호흡기질환자 15명(폐결핵 8명, 만성 폐색성 폐질환 3명, 폐렴 2명, 만성 폐색성 폐질환과 폐결핵이 동반된 환자 2명)을 대조군으로 하여 새로운 폐암 표지자의 가능성이 있는 CYFRA 21-1의 유용성을 조사하였다. CYFRA 21-1의 측정은 면역방사계수측정 kit인 ELSA-CYFRA 21-1을 사용하였다. 결과: 폐암의 조직학적 분류에 따른 CYFRA 21-1의 혈중 측정치는 편평상피세포암이 $20.2{\pm}4.7ng/ml$, 선암이 $7.2{\pm}1.6ng/ml$, 비소세포암이 $15.5{\pm}4.7ng/ml$로 모두 대조군의 $1.7{\pm}0.5ng/ml$보다 유의하게 증가되어 있었다(p<0.01). 또한 비소세포암중 편평상피세포암에서 선암보다 유의하게 증가되어 있었다(p<0.05). 그러나 소세포암에서는 $2.9{\pm}0.9ng/ml$로 대조군과 유의한 차이가 없었다. CYFRA 21-1의 정상 범위를 3.3ng/ml 이내로 하였을때 소세포암에서는 민감도 11.1%, 특이도 65.2% 였으나, 비소세포암에서는 민감도 70.0%, 특이도 62.5%였고 이 중 편평상피 세포암인 경우 민감도 73.7%, 특이도 75%였으며 선암인 경우 63.6%, 78.9%로 산출되었다. 결론: CYFRA 21-1은 비소세포암의 종양 표지자로 유용성이 있을 것으로 생각되며, 특히 편평상피 세포암의 진단에 도움이 될 것으로 생각되었다.

• Tuberculosis and Respiratory Diseases
• /
• 제42권4호
• /
• pp.455-464
• /
• 1995

연구배경: 인체의 결핵균 감염에 대하여 체액성 면역과 세포 매개성 면역이 함께 관여하며 효소결합 면역 분석법으로 결핵균 항원에 대한 항체(IgG)를 측정하는 것은 결핵성 흉막염 진단법으로 이용할 수 있다. 방법: 1992년 5월부터 1994년 7월까지 인하대학교 인하병원에 흉막염으로 입원하였던 환자 중 원인이 확진된 결핵성 흉막염 환자 40예, 비결핵성 흉막염 환자 19예를 대상으로 하여 혈청 및 흉막액에서 PPD 항원과 LAM-B 항원에 대한 IgG 항체가의 흡광도를 측정 하였다. 결과: 1) 결핵성 흉막염군의 흉막액 및 혈청내 PPD와 LAM-B 항체가는 비결핵성 흉악염군보다 유의하게 높았다.(p<0.0005) 2) 혈청내 PPD와 LAM-B 항체가는 흉막액내 항체가 보다 높았다. 3) PPD와 LAM-B에 대한 흉막액 항체와 혈청 항체간에는 의미있는 상관관계를 보였다. 4) 흉막액 PPD 항체의 결핵성 흉막염 진단기준을 0.091로 할 경우 진단적 예민도는 55.0%, 94.7%를 나타내었다. 5) 흉막액 LAM-B 항체의 결핵성 흉막염 진단기준을 0.337로 할 경우 진단적 예민도는 50.0%, 특이도는 94.7%를 나타내었다. 5)결핵성 흉막염군의 진단 양성률은 PPD 피부반응 검사, 흉막액의 양, 활동성 폐결핵 동반여부 등에 의해 영향받지 않았다. 결론: PPD와 LAM-B에 대한 IgG 측정은 결핵성 흉막염의 진단에 도움을 줄 것으로 사료된다. 아울러 PPD와 LAM-B에 대한 IgG는 수동적으로 흉막조직을 통해 혈청에서 흉막액으로 이동함을 제시하고 있다.

• 대한핵의학회지
• /
• 제33권2호
• /
• pp.120-130
• /
• 1999

목적: 갑상선기능항진증 환자에서 병소의 국소화를 위하여 시행하는 Tc-99m MIBI를 이용한 double-phase 부갑상선 신티그라피와 SPECT 방법의 진단적 유용성을 평가하고, 부갑상선의 호산성 세포량과 Tc-99m MIBI 섭취와의 관계를 알고자 하였다. 대상 및 방법: 임상적으로 부갑상선기능항진증이 의심되어 부갑상선 신티그라피가 시행된 16명의 환자중 10명에서 수술이 시행되었고, 여기서 얻은 28개의 부갑상선 조직들을 대상으로 분석하였다. Tc-99m MIBI를 환자에게 정맥주사 후 15분과 2시간에 조기와 지연 바늘구멍 영상을 얻었고 이어서 SPECT 영상을 촬영하였다. 수술로 제거된 부갑상선 조직의 무게와 호산성 세포량을 구하였고, 신티그라피소견을 병리조직 결과와 비교하였다. 결과: 수술로 6개의 부갑상선종과 9개의 부갑상선 비대증이 진단되었다. 조기와 지연 바늘구멍 영상의 민감도, 특이도, 그리고 양성 예측률은 각각 46.7% (7/15),76.9% (10/13), 70% (7/10)과 66.7% (10/15), 92.3% (12/13), 90.9% (10/11)이었다. SPECT 영상은 바늘구멍 영상에 비해 1개의 부갑상선 증식증 병소를 더 진단할 수 있었다. 전체적으로 조기와 지연 바늘구멍 영상과 SPECT 영상을 종합하면 민감도, 특이도, 그리고 양성 예측률은 73.3% (l1/15), 100% (13/13), 100% (11/11)였다. 부갑상선기능항진증의 원인 중부갑상선종은 민감도가 100% (6/6)였으나 부갑상선 증식증은 55.5% (5/9)이었다. 호산성 세포량은 부갑상선종과 부갑상선 증식증에서 정상 부갑상선에 비해 증가되었으나(p<0.0001) 부갑상선종과 부갑상선증식증을 비교하면 호산성 세포량과 무게에는 유의한 차이는 없었다. 결론: Tc-99m MIBI를 이용한 double-phase 부갑상선 신티그라피와 SPECT는 부갑상선기능항진증 환자의 병소 국소화에 효과적인 방법으로 특히 부갑상선종의 국소화에 유용하였다. 부갑상선종과 부갑상선 증식증에서 모두 호산성 세포량이 증가되어 있었으나, 부갑상선종에서는 민감도가 높았고, 부갑상선 증식증에서는 낮았다. 부갑상선증식증에서 민감도가 낮은 원인에 대해서는 더 연구가 필요할 것으로 생각된다.

• 한국동물위생학회지
• /
• 제38권3호
• /
• pp.145-153
• /
• 2015

In this study, we developed a loop-mediated isothermal amplification (LAMP) with hydroxynaphtol blue dye (HNB) for rapid and direct visual detection of porcine circovirus 2 DNA with high sensitivity and specificity. The LAMP was completed in 40 min at $63^{\circ}C$, and the results of the LAMP can be confirmed by naked eye without any detection process. The sensitivity of the LAMP was 10-fold higher than that of the commercial PCR (cPCR) and real time PCR (rPCR) previously reported. In clinical application, the PCV2 detection rate of the LAMP was the same on porcine tissue samples (75.0%, 36/48) between porcine blood samples (75.0%, 39/52). The PCV2 detection rate (75.0%) of LAMP was higher than those of the cPCR and rPCR (67.3%, 35/52) in blood samples. In conclusion, the LAMP developed in the study could be an useful alternative method for the detection of PCV2 in the swine disease diagnostic laboratories.

• IMMUNE NETWORK
• /
• 제2권3호
• /
• pp.175-181
• /
• 2002

Background: S100A6 is a calcium-binding protein overexpressed in several tumor cell lines including melanoma with high metastatic activity and involved in various cellular processes such as cell division and differentiation. To detect S100A6 protein in patient' samples (ex, blood or tissue), it is essential to produce a monoclonal antibody specific to the protein. Methods: First, cDNA coding for ORF region of human S100A6 gene was amplified and cloned into the expression vector for GST fusion protein. We have produced recombinant S100A6 protein and subsequently, monoclonal antibodies to the protein. The specificity of anti-S100A6 monoclonal antibody was confirmed using recombinant S100A recombinant proteins of other S100A family (GST-S100A1, GST-S100A2 and GST-S100A4) and the cell lysates of several human cell lines. Also, to identify the specific recognition site of the monoclonal antibody, we have performed the immunoblot analysis with serially deleted S100A6 recombinant proteins. Results: GST-S100A6 recombinant protein was induced and purified. And then S100A6 protein excluding GST protein was obtained and monoclonal antibody to the protein was produced. Monoclonal antibody (K02C12-1; patent number, 330311) has no cross-reaction to several other S100 family proteins. It appears that anti-S100A6 monoclonal antibody reacts with the region containing the amino acid sequence from 46 to 61 of S100A6 protein. Conclusion: These data suggest that anti-S100A6 monoclonal antibody produced can be very useful in development of diagnostic system for S100A6 protein.

• Tuberculosis and Respiratory Diseases
• /
• 제67권4호
• /
• pp.318-324
• /
• 2009

Background: A diagnosis and treatment of chest wall tuberculosis (CWTB) is both difficult and controversial. The aim of this study was to collect information on the optimal treatment for CWTB. Methods: The clinical features, radiographic findings, and treatment outcomes of 26 patients, who underwent surgery and were diagnosed histopathologically, were retrospectively analyzed. Results: The most common presenting symptom was a palpable mass found in 24 patients (92.3%). In all patients, CT revealed a soft tissue mass that was accompanied by a central low density, with or without peripheral rim enhancement. The sensitivity and specificity of the bone scintigram for bone involvement were 87.5% and 100%, respectively. CWTB was diagnosed preoperatively by aspiration cytology and smear for acid-fast bacilli in five out of 11 patients. Twenty-three patients (88.5%) underwent a radical excision and three underwent incision/drainage or an incisional biopsy. The duration of antituberculous medication was 7.5${\pm}$3.98 months with a follow-up period of 28.2${\pm}$26.74 months. Among the 20 patients who completed their treatment, nine received chemotherapy for six months or less and 11 received chemotherapy for nine months or more. Two patients had a recurrence four and seven months after starting their medication. Conclusion: A 6 month regimen may be appropriate for CWTB patients who have undergone a complete excision.

• IMMUNE NETWORK
• /
• 제1권3호
• /
• pp.260-265
• /
• 2001

Transforming growth $factor-{\beta}1$ ($TGF-{\beta}1$) is a multipotent growth factor affecting development, homeostasis and tissue repair. Many kinds of malignant tissues were reported to overexpress transforming growth $factor-{\beta}1$ ($TGF-{\beta}1$) gene. However, a little work has been done on the circulating $TGF-{\beta}1$ and the association of $TGF-{\beta}1$ with progression in patients with malignant tumors. In this study, we measured the plasma level of $TGF-{\beta}1$ in gastric cancer and prostate cancer patients and evaluated the utility of plasma $TGF-{\beta}1$ as a possible tumor marker. We used Enzyme-linked immunosorbent assay (ELISA) system in order to measure plasma $TGF-{\beta}1$ level in 134 gastric cancer patients, 50 prostate cancer patients and 290 normal controls. And the tumor marker, carcinoembryonic antigen (CEA), prostate-specific antigen (PSA), was compared with $TGF-{\beta}1$ in the aspects of sensitivity and specificity. The mean plasma $TGF-{\beta}1$ levels were $1.219{\pm}0.834$ (0.272-5.772) ng/mL in normal controls, $5.964{\pm}3.218$ (0.845-18.124) ng/mL in gastric cancer and $4.140{\pm}2.345$ (1.108-13.302) ng/mL in prostate cancer. In gastric cancer patients difference in plasma $TGF-{\beta}1$ level was not detected according to cancer stage. In comparison with other tumor marker (CEA, PSA) $TGF-{\beta}1$ is more potent in sensitivity. These results indicate that the plasma $TGF-{\beta}1$ level can be a potent tumor marker in gastric cancer and prostate cancer.

• IMMUNE NETWORK
• /
• 제3권1호
• /
• pp.16-22
• /
• 2003

Background: The S100A2 gene, also known as S100L or CaN19, encodes a protein comprised of 99-amino acids, is a member of the calcium-binding proteins of EF-hand family. According to a recent study, this gene was over-expressed in several early and malignant carcinomas compared to normal tissues. To elucidate the role of S100A2 protein in the process during carcinogenesis, production of monoclonal antibody specific to the protein is essential. Methods: First, cDNA sequence coding for ORF region of human S100A2 gene was amplified and cloned into an expression vector to produce GST fusion protein. Recombinant S100A2 protein and subsequently, monoclonal antibody to the protein were produced. The specificity of anti-S100A2 monoclonal antibody was confirmed by immunoblot analysis of cross reactivity to other recombinant proteins of S100A family (GST-S100A1, GST-S100A4 and GST-S100A6). To confirm the relation of S100A2 to cervical carcinogenesis, S100A2 protein in early cervical carcinoma tissue was immunostained using the monoclonal antibody. Results: GST-S100A2 recombinant protein was purified by affinity chromatography and then fusion protein was cleaved and S100A2 protein was isolated. The monoclonal antibody (KK0723; Korean patent pending #2001-30294) to the protein was produced and the antibody did not react with other members of EF-hand family proteins such as S100A1, S100A4 and S100A6. Conclusion: These data suggest that anti-S100A2 monoclonal antibody produced in this study can be very useful for the early detection of cervical carcinoma and elucidation of mechanism during the early cervical carcinogenesis.

• Investigative Magnetic Resonance Imaging
• /
• 제3권2호
• /
• pp.159-166
• /
• 1999

Purpose : To evaluate the effect of rotational correlation time (${\tau}_R$) and the possible related changes of other parameters, ${\tau}_M,{\;}{\tau}_S,{\;}and{\;}(\tau}_V$ of gadolinium (Gd) chelate on T1 relaxation enhancement in two pool model. Materials and Methods : The NMRD (Nuclear Magnetic Relaxation Dispersion) profiles were simulated from 0.02 MHz to 800 MHz proton Larmor frequency for different values of rotational correlation times based on Solomon-Bloembergen equation for inner-sphere relaxation enhancement. To include both unbound pool (pool A) and bound pool (pool B), the relaxivity was divided by contribution from unbound pool and bound pool. The rotational correlation time for pool A was fixed at the value of 0.1 ns, which is a typical value for low molecular weight complexes such as Gd-DTPA in solution and ${\tau}_R$ for pool B was changed from 0.1 ns to 20 ns to allow the slower rotation by binding to macromolecule. The fractional factor of was also adjusted from 0 to 1.0 to simulate different binding ratios to macromolecule. Since the binding of Gd-chelate to macromolecule cab alter the electronic environment of Gd ion and also the degree of bulk water access to hydration site of Gd-chelate, the effects of these parameters were also included. Results : The result shows that low field profiles, ranged from 0.02 to 40 MHz, and dominated by contribution from bound pool, which is bound to macromolecule regardless of binding ratios. In addition, as more Gd-chelate bound to macromolecule, sharp increase of relaxivity at higher field occurs. The NMRD profiles for different values of ${\tau}_S$ show the enormous increase of low field profile whereas relaxivity at high field is not affected by ${\tau}_S$. On the other hand, the change in ${\tau}$V does not affect low field profile but strongly in fluences on both inflection fie이 and the maximum relaxivity value. The results shows a fluences on both inflection field and the maximum relaxivity value. The results shows a parabolic dependence of relaxivity on ${\tau}_M$. Conclusion : Binding of Gd-chelate to a macromolecule causes slower rotational tumbling of Gd-chelate and would result in relaxation enhancement, especially in clinical imaging field. However, binding to macromolecule can change water enchange rate (${\tau}_M$) and electronic relaxation ($T_le$) vis structural deformation of electron environment and the access of bulk water to hydration site of metal-chelate. The clinical utilities of Gd-chelate bound to macromolecule are the less dose requirement, the tissue specificity, and the better perfusion and intravascular agents.

• Restorative Dentistry and Endodontics
• /
• 제24권1호
• /
• pp.40-48
• /
• 1999

This study was designed to examine the specificities of the designed primers for F. nucleatum and F. necrophorum and to compare the PCR results using clinical samples with those of the anaerobic culture method. F. nucleatum and F. necrophorum spp. are frequently isolated in infected root canals, and they are related to periapical diseases. F. nucleatum(VPI 10197) and F. necrophorum(ATCC 25286) were used as references for PCR reaction, and thirty five teeth with one canal and periapical lesion were used. The samples were cultured anaerobically and identified using Rapid ID 32A(BioMerieux Vitek, Inc., France) as biochemical battery. In the GenBank database, species-specific PCR primers(nuc1/nuc2 primers for F. nucleatum and nec1/nec2 primers for F. necrophorum) were designed from the 16S ribosomal DNA(rDNA) sequences of F. nucleatum(accession number M58683) and F. necrophorum(accession number AF044948). PCR procedures of F. nucleatum(VPI 10197) and F. necrophorum (ATCC 25286) were simulated on a computer software. Amplify(v.1.2${\beta}$ for Macintosh). 820 bps and 817 bps of nucleotides were expected, respectively. Using extracted DNAs with QiaAmp tissue kit(Qiagen co., Germany), PCR was done. The results were as follows : 1. The nuc1/nuc2 primers produced an amplicon of 820 bps and the nec1/nec2 primers produced an amplicon of 817 bps. 2. The nuc1/nuc2 primers and the nec1/nec2 primers were specific and did not react with species other than the designated ones(i.e. nuc1/nuc2 primers did not produce amplicons for F. necrophorum, and vice versa.). And the PCR products of Porphyromonas endodontalis(ATCC 35406), Porphyromonas gingivalis(ATCC 33277), Prevotella intermedia(ATCC 25611), and Prevotella nigrescens(ATCC 33563), frequently isolated in infected root canals and periapical lesions, were not amplified by the primers specific for Fusobacterium nucleatum and Fusobacterium necrophorum. 3. This method utilizing PCR could detect F. nucleatum and F. necrophorum in clinical samples, while anaerobic culture method could detect neither.